1 April 2016 - The April 2016 issue of the Schedule sees a number of new/revised listings such as arsenic trioxide (Phenasen), atazanavir sulphate with cobicistat (Evotaz), emtricitabine with elvitegravir and cobicistat and tenofovir alafenamide fumarate (Genvoya), nadroparin calcium (Fraxiparin/Fraxiparine Forte) and netupitant with palonosetron hydrochloride (Akynzeo).

All new and revised PBS listings have been entered into the MAESTrO database.

For more details, go to: http://www.pbs.gov.au/browse/changes